Institutional investors and analysts
Investor Relations UK
GSK plc
980 Great West Road
Brentford
Middlesex TW8 9GS
Tel: +44 (0)20 8047 5000
Email: GSK.Investor-Relations@gsk.com
US Investor Relations and Response Centre
GSK plc
FMC Tower at Cira Centre South
2929 Walnut Street, Suite 1700
Philadelphia, PA 19104
Toll free: +1 888 825 5249
Tel: +1 215 751 4000
Email: GSK.Investor-Relations@gsk.com
-
Nick Stone, SVP, Head of IR (London)
+44 7717 618834
-
Camilla Campbell, IR Director (London)
+44 7803 050238
-
Frannie DeFranco, IR Director (Philadelphia)
+1 215 751 4855
-
James Dodwell, IR Director (London)
+44 7881 269066
-
Jeff McLaughlin, IR Director (Philadelphia)
+1 215 751 7002
-
Steph Mountifield, IR Director (London)
+44 7796 707505
-
Mick Readey, IR Director (London)
+44 7990 339653
-
Josh Williams, IR Director (London)
+44 7385 415719
Corporate Access
-
Laura Elliott, IR Coordinator (London)
+44 7788 387335
-
Souheil Salah, IR Operations Director (London)
+44 7557 290490
-
Christine Timmons, IR Coordinator (Philadelphia)
+1 215 751 4611
Registrar contact details
Equiniti Limited
Aspect House
Spencer Road
Lancing
West Sussex BN99 6DA
Website: www.shareview.co.uk
Shareholder enquiries: +44 (0) 371 384 2991
Employee shareholder enquiries: +44 (0) 371 384 2881
Share dealing and enquiries*: +44 (0) 345 603 7037
Lines are open 8.00am to 5.30pm for dealing, and until 6.00pm for enquiries, Monday to Friday.
EQi investment account and ISA enquiries*: +44 (0) 345 0700 720
Lines are open 8.00am to 5.30pm, Monday to Friday.
Times quoted are UK business hours and exclude UK public holidays. Please use the Country code if calling from outside the UK. Services marked * are generally only available to UK tax residents.
JP Morgan ADR shareholder services can be contacted at:
EQ Shareowner Services
PO Box 64504
St. Paul
MN 55164-0504
Overnight correspondence to be sent to:
EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights
MN 55120-4100
Website: www.shareowneronline.com
Tel: +1 877 353 1154 (US toll free)
Tel: +1 651 453 2128 (outside the USA)
Tel: +1 800 428 4237 for Global Invest Direct
Email anytime at: https://www.shareowneronline.com/informational/contact-us/
The Depositary also provides Global Invest Direct, an ADS purchase/sale and dividend reinvestment plan for ADR holders. Current participants in the BNY Global BuyDIRECT will receive a welcome letter via US Mail with instructions for activating their new Global Invest Direct account.
Further information regarding signing up for Global Invest Direct can be obtained by visiting www.shareowneronline.com or call the above helpline number to obtain an enrollment pack.
GSK employee shareholder enquiries
Tel: 0808 234 4391
Glaxo Wellcome and SmithKline Beecham corporate PEPs
The Share Centre Limited
Oxford House
Oxford Road
Aylesbury
Bucks HP21 8SZ
Corporate share dealing facility
Equatex UK
1 King William Street
London EC4N 7AR
Tel: 0808 234 9321 (UK)
Tel: +800 4020 0032 (International)
Email: www.equateplus.com
Computershare UK
Computershare Plan Managers
Bridgwater Road
Bristol
BS99 6AP
Tel: (+44) 117 240 2520 (Europe)
Tel: (+1) 732 491 0715 (North or South America)
Toll Free: (+1) 866 627 2097 (North America)
Tel: (+61) 3 9415 4824 (Australia or Asia-Pacific region)
Email: GSKLTI@computershare.com
Corporate share dealing facility
Equatex US Inc.
140 BroadwaySuite
2211 New York,
NY 10005
Tel: +41 44 403 61 00
www.equateplus.com
Computershare US
Computershare Plan Managers
Bridgwater Road
Bristol
BS99 6AP
Tel: (+44) 117 240 2520 (Europe)
Tel: (+1) 732 491 0715 (North or South America)
Toll Free: (+1) 866 627 2097 North or South America
Tel: (+61) 3 9415 4824 (Australia or Asia-Pacific region)
Email: GSKLTI@computershare.com
Debt investors
Timothy Woodthorpe
Senior Vice President and Group Treasurer
Email: cf.treasury@gsk.com
GSK Investor Relations
Tel: +44 (0)20 8047 5000
Email: GSK.Investor-Relations@gsk.com
